DEFENSIN GENE COPY NUMBER AND MUCOSAL INNATE IMMUNITY

防御素基因拷贝数和粘膜先天免疫

基本信息

  • 批准号:
    8357354
  • 负责人:
  • 金额:
    $ 7.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Gene copy number (GCN) variation is a newly described phenomenon, which likely contributes significant phenotypic variability within populations. Substantial GCN variation is present in genes that encode defensins, cationic antimicrobial peptides that play an important role in innate immunity to infectious diseases. The gene encoding ¿-defensin 2, which is a key part the innate immune response in skin and mucosal surfaces, varies from 2-12 copies per diploid genome. Recent evidence has linked variation in the BD2 GCN with susceptibility to idiopathic diseases: low GCN increases the risk for Crohn's disease of the colon, while high GCN is associated with increased risk of psoriasis. We recently used the rhesus macaque model to demonstrate that, like in humans, BD2 expression is induced by Helicobacter pylori, a common gastric pathogen that is the causative agent of peptic ulcer and increases the risk for gastric cancer. Furthermore, our preliminary data suggest that rhesus macaques, like humans, have marked variation in BD2 GCN. We hypothesize that variation in BD2GCN is reflected in expression levels of BD2, and that these differences will affect the outcome of infection with H. pylori. In Aim 1 we will characterize GCN and allelic diversity in the BD2 gene of macaques, and examine the relationship between GCN and expression of BD2 in primary cell culture. In Aim 2 we will identify three groups of macaques with low, intermediate, or high BD2 GNC, and compare their gastric biota and response to experimental challenge with H. pylori. Since only about 5to 10% of humans infected with H. pylori will have clinical sequelae, while the remainder will have only asymptomatic gastritis, there is considerable interest in understanding host factors that are associated with disease. Understanding the functional relationship between genetic variations in the BD2 gene and H. pylori infection will therefore not only expand our knowledge of the relationship between the innate immune response and infection, but may also provide a translational link to better understand who may benefit from treatment of H. pylori in order to prevent peptic ulcer and gastric cancer.
这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的, 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量, 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 基因拷贝数(GCN)变异是一种新发现的现象,它可能导致群体内显著的表型变异。大量的GCN变异存在于编码防御素的基因中,防御素是阳离子抗微生物肽,在对感染性疾病的先天免疫中起重要作用。基因编码- 防御素2是皮肤和粘膜表面先天免疫应答的关键部分,每个二倍体基因组有2-12个拷贝。最近的证据表明,BD 2 GCN的变异与特发性疾病的易感性有关:低GCN增加了结肠克罗恩病的风险,而高GCN与银屑病的风险增加有关。我们最近使用恒河猴模型来证明,像在人类中一样,BD 2的表达是由幽门螺杆菌诱导的,幽门螺杆菌是一种常见的胃病原体,是消化性溃疡的病原体,并增加胃癌的风险。此外,我们的初步数据表明,恒河猴,像人类一样,在BD 2 GCN有显着的变化。我们假设BD 2 GCN的变异反映在BD 2的表达水平上,并且这些差异将影响H.幽门。在目标1中,我们将描述猕猴BD 2基因的GCN和等位基因多样性,并检查GCN与原代细胞培养物中BD 2表达之间的关系。在目标2中,我们将确定三组具有低、中或高BD 2 GNC的猕猴,并比较它们的胃生物群和对H.幽门。由于只有5%-10%的人感染H.幽门螺杆菌感染者会有临床后遗症,而其余的人只会有无症状的胃炎,因此人们对了解与疾病相关的宿主因素有相当大的兴趣。了解BD 2基因的遗传变异与H.因此,幽门螺杆菌感染不仅将扩大我们对先天免疫应答和感染之间关系的认识,而且还可能提供一种翻译联系,以更好地了解哪些人可能从幽门螺杆菌治疗中获益。幽门螺杆菌,以防止消化性溃疡和胃癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAY V. SOLNICK其他文献

JAY V. SOLNICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAY V. SOLNICK', 18)}}的其他基金

Functional Plasticity in the Helicobacter pylori Type IV Secretion System
幽门螺杆菌 IV 型分泌系统的功能可塑性
  • 批准号:
    8743130
  • 财政年份:
    2014
  • 资助金额:
    $ 7.56万
  • 项目类别:
Functional Plasticity in the Helicobacter pylori Type IV Secretion System
幽门螺杆菌 IV 型分泌系统的功能可塑性
  • 批准号:
    8889192
  • 财政年份:
    2014
  • 资助金额:
    $ 7.56万
  • 项目类别:
Functional Plasticity in the Helicobacter pylori Type IV Secretion System
幽门螺杆菌 IV 型分泌系统的功能可塑性
  • 批准号:
    9301473
  • 财政年份:
    2014
  • 资助金额:
    $ 7.56万
  • 项目类别:
Functional Plasticity in the Helicobacter pylori Type IV Secretion System
幽门螺杆菌 IV 型分泌系统的功能可塑性
  • 批准号:
    9094671
  • 财政年份:
    2014
  • 资助金额:
    $ 7.56万
  • 项目类别:
HELICOBACTER PYLORI AND THE GASTRIC MICROBIAL COMMUNITY IN RHESUS MACAQUES
恒河猴中的幽门螺杆菌和胃微生物群落
  • 批准号:
    8357316
  • 财政年份:
    2011
  • 资助金额:
    $ 7.56万
  • 项目类别:
PREVENTION OF ACTIVE TUBERCULOSIS BY INFECTION WITH H PYLORI
通过幽门螺杆菌感染预防活动性结核病
  • 批准号:
    8357314
  • 财政年份:
    2011
  • 资助金额:
    $ 7.56万
  • 项目类别:
MODULATION OF OUTER MEMBRANE PROTEIN EXPRESSION IN HELICOBACTER PYLORI
幽门螺杆菌外膜蛋白表达的调节
  • 批准号:
    8357315
  • 财政年份:
    2011
  • 资助金额:
    $ 7.56万
  • 项目类别:
ROLE OF H PYLORI OUTER MEMBRANE PROTEINS IN COLONIZATION AND HOST RESPONSE
幽门螺杆菌外膜蛋白在定植和宿主反应中的作用
  • 批准号:
    8357312
  • 财政年份:
    2011
  • 资助金额:
    $ 7.56万
  • 项目类别:
GENE EXPRESSION DURING H PYLORI-HOST INTERACTION
幽门螺杆菌-宿主相互作用期间的基因表达
  • 批准号:
    8357261
  • 财政年份:
    2011
  • 资助金额:
    $ 7.56万
  • 项目类别:
PROPHYLACTIC AND THERAPEUTIC IMMUNIZATION AGAINST H PYLORI IN RHESUS MACAQUES
恒河猴中针对幽门螺杆菌的预防性和治疗性免疫
  • 批准号:
    8357306
  • 财政年份:
    2011
  • 资助金额:
    $ 7.56万
  • 项目类别:

相似海外基金

Expression of antimicrobial cationic peptides in plants
抗菌阳离子肽在植物中的表达
  • 批准号:
    181104-1995
  • 财政年份:
    1996
  • 资助金额:
    $ 7.56万
  • 项目类别:
    Strategic Projects - Group
Expression of antimicrobial cationic peptides in plants
抗菌阳离子肽在植物中的表达
  • 批准号:
    181104-1995
  • 财政年份:
    1995
  • 资助金额:
    $ 7.56万
  • 项目类别:
    Strategic Projects - Group
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了